SEPTInvestingStart Free

VIVS 10-Q: SEC filing

VivoSim Labs

Filed with the SEC on · accession 0001193125-26-458330

VIVS filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

VivoSim Labs filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial results, equity activity, and subsequent events including a license agreement with Viscient Biosciences.

For details, click here →How to read a 10-Q →

Key details

License agreement counterpartyViscient Biosciences
Subsequent event partyOrganovo, Inc.
Subsequent event partySan Diego Inspire2 LLC

✦ Ask GOAX AI about this filing — what it means for VIVS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VIVS?

Click here

Frequently asked questions

What did VIVS file with the SEC on Nov 12, 2026?

VIVS filed a 10-Q (SEC filing). VivoSim Labs filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial results, equity activity, and subsequent events including a license agreement with Viscient Biosciences.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other VIVS SEC filings

Get alerts when VIVS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
VIVS overviewVIVS analysisVIVS newsLatest SEC filings